ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Verona Pharma launches late-stage COPD trial programme pharmatimes
September 27, 2020Verona Pharma has initiated phase III trials to evaluate the safety and efficacy of nebulised ensifentrine in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).
Pharma Sources Insight July 2025
